Genetic targeting of B-RafV600E affects survival and proliferation and identifies selective agents against BRAF-mutant colorectal cancer cells.
Mol Cancer. 2014 May 24;13:122. doi: 10.1186/1476-4598-13-122.
Mol Cancer. 2014.
PMID: 24885690
Free PMC article.